Hohimer Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,437
Closed -$2.79M 276
2024
Q4
$2.79M Buy
+20,437
New +$2.79M 0.53% 69